Bulk Pembrolizumab from Canada
Pembrolizumab is a PD-1 inhibitor monoclonal antibody for immuno-oncology applications. Classifies in HTS 3002.13.0090 as unmixed biotech immunological product regulating immune checkpoint processes. Not for retail sale.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Binding affinity data (KD value) supports immunological classification
• Controlled substance? Check DEA scheduling for conjugates
• Use GxP-certified couriers for chain of custody